Literature DB >> 10510139

Pharmacokinetics of bambuterol during oral administration to asthmatic children.

H Ahlström1, J Alvero, R Alvero, R Espos, L Fajutrao, J Herrera, B Kjellman, J Kubista, C Leviste, P Meyer, G Oldaeus, A Siricururat, P Vichyanond, G Wettrell, E Wong, L Laxmyr, L Nyberg, H Olsson, E Weibull, J Rosenborg.   

Abstract

AIMS: To investigate dose proportionality, dosing frequency, and ethnic aspects of the pharmacokinetics of bambuterol in asthmatic children, and to discuss the relationship with previous observations in adults.
METHODS: Forty-eight children in four different studies completed two double-blind bambuterol treatments each (daily doses of bambuterol hydrochloride): 12 preschool (5 mg x 2 vs 10 mg) and 12 school (10 mg vs 20 mg) Caucasians, 12 preschool (2.5 mg vs 5 mg), and 12 school (10 mg vs 20 mg) Orientals. Peak plasma concentrations and dosing interval area under curve (AUC) of bambuterol and the active metabolite terbutaline were assessed at steady state. Treatment differences were analysed statistically within each study. Differences between the studies and the relation to steady-state AUC in adults were described.
RESULTS: Dose proportionality was seen for terbutaline but not for bambuterol. Twice-daily dosing (2 x AUC(0,12 h)) could not be shown to differ from once-daily dosing (AUC(0,24 h)) in the preschool Caucasians. Mean AUC of terbutaline was 128 and 242 nmol l-1 h in the preschool Caucasians (5 mg/12 h; 10 mg/24 h), 213 and 406 nmol l-1 h in the Caucasian school children (10 mg; 20 mg), 87.4 and 202 nmol l-1 h in the Oriental preschool children (2.5 mg; 5 mg), and 356 and 640 nmol l-1 h in the Oriental school children (10 mg; 20 mg). Oriental school children had higher plasma concentrations of bambuterol and terbutaline than Caucasian school children. The strict ethnic implication of the difference could not be elucidated, because demographic data were not perfectly matched. Terbutaline AUC was only moderately increased in the Caucasian school children compared with Caucasian adults. The increase was more pronounced in Oriental children and in some preschool Caucasians. The highest concentration of terbutaline, 58 nmol l-1, was seen in an Oriental school child after a 20 mg dose.
CONCLUSIONS: Caucasian school children can be given bambuterol hydrochloride very much as Caucasian adults, 10 or 20 mg once daily, but Oriental preschool and school children plus preschool Caucasians should be given lower doses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510139      PMCID: PMC2014342          DOI: 10.1046/j.1365-2125.1999.00028.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Determination of bambuterol, a prodrug of terbutaline, in plasma and urine by gas chromatography/mass spectrometry.

Authors:  C Lindberg; S Jönsson; J Paulson; A Tunek
Journal:  Biomed Environ Mass Spectrom       Date:  1990-04

2.  Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.

Authors:  A Tunek; L A Svensson
Journal:  Drug Metab Dispos       Date:  1988 Sep-Oct       Impact factor: 3.922

3.  Metabolism of bambuterol in rat liver microsomes: identification of hydroxylated and demethylated products by liquid chromatography mass spectrometry.

Authors:  C Lindberg; C Roos; A Tunek; L A Svensson
Journal:  Drug Metab Dispos       Date:  1989 May-Jun       Impact factor: 3.922

Review 4.  The design and bioactivation of presystemically stable prodrugs.

Authors:  L A Svensson; A Tunek
Journal:  Drug Metab Rev       Date:  1988       Impact factor: 4.518

5.  Hydrolysis of 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro.

Authors:  A Tunek; E Levin; L A Svensson
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

6.  Bambuterol: effective in nocturnal asthma.

Authors:  G R Petrie; J Y Chookang; W U Hassan; J F Morrison; J F O'Reilly; S B Pearson; J M Shneerson; O T Tang; A C Ning; M L Turbitt
Journal:  Respir Med       Date:  1993-11       Impact factor: 3.415

7.  Pharmacokinetic parameters of terbutaline in healthy man. An overview.

Authors:  L Nyberg
Journal:  Eur J Respir Dis Suppl       Date:  1984

8.  Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.

Authors:  U Bang; L Nyberg; J Rosenborg; J Viby-Mogensen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

9.  A new approach to determining cholinesterase activities in samples of whole blood.

Authors:  K B Augustinsson; H Eriksson; Y Faijersson
Journal:  Clin Chim Acta       Date:  1978-10-16       Impact factor: 3.786

10.  Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.

Authors:  A M Fugleholm; T B Ibsen; L Laxmyr; U G Svendsen
Journal:  Eur Respir J       Date:  1993-11       Impact factor: 16.671

View more
  2 in total

1.  Characteristics of the formation of systems activity in the brain and autonomic functions in children in conditions of the European North (discussion paper).

Authors:  S I Soroko; E A Burykh; S S Bekshaev; G V Sidorenko; E G Sergeeva; A E Khovanskikh; B N Kormilitsyn; S N Moralev; O V Yagodina; L K Dobrodeeva; I A Maksimova; O V Protasova
Journal:  Neurosci Behav Physiol       Date:  2007-11

2.  Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.

Authors:  J Rosenborg; P Larsson; L Nyberg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.